Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Still Untitled, Xavier Le Roy with Scarlet Yu at The Wanås Foundation

Can I show you my sculpture? In July and August, together with visitors to the sculpture park, Xavier Le Roy, Scarlet Yu and the Still Untitled team explore the concept of sculpture within the context of Still Untitled and spread it through encounters in the park and beyond. Still Untitled is sculptures that are embodied and presented by people to people. Visitors are invited to participate in one-day workshops that examine the relationship between live art and sculpture relative to time and public space. Anyone is welcome to sign up for the workshop and no previous knowledge or experience

Insplorion sells an XNano system to Professor Yalong Bai at Shanghai Academy of Agricultural Sciences (SAAS), China

Professor Yalong Bai at Shanghai Academy of Agricultural Sciences, School of Environmental Science & Engineering and his group will use the XNano System for research within detection of pathogens, viruses and bacterium. The sale has been conducted by Insplorion’s Chinese distributor Honoprof with an order value of almost 500 000 kr."We see the XNano beneficial when it comes to life science applications and we predict that it will be a valuable tool for our studies on detection of pathogens, viruses and bacterium", comments Professor Yalong Bai, Shanghai Academy of Agricultural Sciences.

Alfa Laval wins SEK 120 million energy efficiency order

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has won an order to supply large heat exchangers to a petrochemical plant in China. The order has a value of approximately SEK 120 million. It is booked in the Welded Heat Exchangers unit of the Energy Division, with deliveries scheduled for 2018 and 2019.The order comprises of large Alfa Laval OLMI heat exchangers to be used to recover and reuse energy in different steps in the chemical process of producing components for polystyrene production. “Alfa Laval offers an extensive product range of heat

Quarterly Report III 17/18

September 2017 – May 2018, Diamyd Medical AB (publ), Fiscal year 2017/2018September 1, 2017 – May 31, 2018 ·  Net result amounted to MSEK -32.5 (-19.0), of which the third quarter constituted of MSEK -12,6 (-8.3). The change compared with the previous year relates to the DIAGNODE-2 trial that started this financial year. ·  Result per share, before and after dilution, amounted to SEK -0.6 (-0.6), of which the third quarter constituted of SEK -0.2 (-0.3) ·  Cash flow from operating activities amounted to MSEK -32.6 (-16.0) of which the third quarter constituted of MSEK -9.6 (-5.4)

Converting factories into innovation platforms to make production more efficient in Finland

The ecosystem of the Finnish manufacturing industry is taking the digital leap, and it utilises the strong corporate and research sector of the IoT industry in this transformation. The aim is to convert factories into innovation platforms and have them share their successful solutions to improve efficiency and competitiveness in the manufacturing industry.“The “Reboot Finland IoT Factory” ecosystem enables the use of IoT products manufactured in the SME sector in various industrial environments. It also enables quick experiments for applying the latest research results in order to develop

Invitation to the presentation of Ahlsell’s Q2 report 2018

Ahlsell, the leading Nordic distributor of installation products, tools and supplies, will publish its quarterly report for the second quarter 2018 on July 19 at 07:30 CEST. At 10.00 CEST there will be a webcasted conference call in which Johan Nilsson, CEO, and Kennet Göransson, CFO, will present the report. The presentation will be held in English and can be followed both on the web and by phone. Link to the webcast:http://www.financialhearings.com/event/10699 Numbers to the conference call:SE: +46 8 5055 6453UK: +44 203 008 9811US: +1 855 831 5944 The presentation

Inwido and IBM Watson IoT connect Europe - one window at a time

Inwido, Europe’s largest supplier of windows and a leading door supplier is working with IBM to advance the European smarter-home eco-system. As part of its digital future strategy, Inwido is using IBM’s cloud-based Watson IoT Platform and AI consulting services to gather and analyze structured and unstructured data from the smarter home to ensure the safety, security and comfort of home owners.Inwido’s solution also opens up for including other smarter home eco-system participants in areas such as climate control, health, and environmental consciousness. Inwido is the first supplier of

Humana expands in Finland

Humana AB acquires Luotsimaja Oy with operations within psychosocial treatment for children and youth in Pori, Western Finland. The acquisition entails a geographic expansion and strengthens our service offering.Humana AB has entered an agreement to acquire all shares in Luotsimaja Oy. The transfer will take place immediately and the operations of Luotsimaja Oy will be included in Arjessa, Humana’s Finnish subsidiary. Luotsimaja Oy is currently operating a specialised treatment operation for children and youth in Pori in western part of Finland. Revenues in Luotsimaja Oy amounted to

Prof. Catharina Svanborg appointed as Chief Medical Officer of HAMLET Pharma, overseeing clinical trials

HAMLET Pharma has formally appointed Prof Catharina Svanborg Chief Medical Officer (CMO) of the company. The company thereby ensures that Prof. Svanborg, who is the company Chairman and founder of HAMLET Pharma, will continue and further develop her involvement in research and drug development. Specifically, this step allows the company to ensure critical coordination and oversight of clinical trials and regulatory processes.Prof Svanborg says, “Clinical trials are already underway at the University Hospital in Prague. The physicians there are committed and truly excited about the unique

Alimak Group gets construction hoist order for Karlatornet

Serneke has placed an order with Alimak Group’s Construction Equipment for hoists to be used in the building of Karlatornet in Gothenburg.Karlatornet with its 245 metres will be the tallest building in the Nordic region and is expected to be complete in 2021. Skidmore, Owings & Merrill, the architects for Karlatornet, are also behind some of the world's tallest and most spectacular buildings such as Burj Khalifa and One World Trade Center. The order includes five hoists, of which one is a Mammoth TM with a payload of up to 5,500 kg. This is the first time the Mammoth will be used in

Skanska builds new high school in Sherwood, USA, for USD 77 M, about SEK 640 M

Skanska has signed a contract with the Sherwood School District to construct a new high school for the school district in Portland, Oregon, USA. The contract is worth USD 77 M, about SEK 640 M, which will be included in the US order bookings for the second quarter of 2018.The project consists of a new 32,800 square meter facility for the school district. The school is planned to accommodate 2,000 students, with the ability to expand to 2,400 students. The campus will include a performing arts center, science and technology classrooms, and multiple gymnasiums. Additionally, it will also

AstraZeneca PLC Announces Lynparza significantly delays disease progression in Phase III 1st-line SOLO-1 trial for ovarian cancer

Lynparza met primary endpoint of progression-free survival in women with BRCA-mutated advanced ovarian cancer and showed a safety profile consistent with previous trials AstraZeneca and MSD's Lynparza is the only PARP inhibitor to demonstrate significant activity in the 1st-line maintenance settingThis announcement contains inside information 27 June 2018 07:00 BST   AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) today announced positive results from the randomised, double-blinded, placebo-controlled, Phase III SOLO-1

YIT sells part of its plot in Pushkin, near St. Petersburg

YIT Corporation Press release, June 27, 2018, at 09:00 a.m.YIT has sold a part of its plot in Pushkin, which is located to the south of St. Petersburg. YIT is building the INKERI low-rise apartment complex on the plot. The object of the sale is 5.4 hectares and the purchase price is approximately EUR 15 million. The buyer is FSK Lider, a Russian real estate development company. The new owner of the plot can build a total of 50,000 square metres of residential buildings in the area. Plots in the area have the required development documents and building permits granted by the authorities.

HIDDN: Awarded ISO 9001 certification

(Oslo, 27 June 2018) Hiddn Solutions ASA (HIDDN) has been awarded the internationally recognised ISO 9001 certification, proving that our quality management system is robust and fit to ensure that Hiddn products and services meet the needs of our clients.  “We are proud to have achieved ISO 9001 certification, which is an important precondition for volume production. The ISO 9001 certification is an assurance that we have robust, clearly defined procedures in place. Our quality management system applies to all our business areas, and this award lends credibility to our capacity to

NATTO: MANDATORY NOTIFICATION OF TRADE AND DISCLOSURE OF LARGE SHAREHOLDING

KG Investment Company AS (org.nr. 986 357 009) has on June 26th entered into a binding agreement to sell 2 152 317 shares in NattoPharma ASA (org. nr. 987 774 339) to TG Montgomery AS (org. nr. 988 462 624) at a price of NOK 10,50 per share. After completion of this transaction, which is expected to take place before the end of July 2018, KG Investment Comp AS no longer hold any shares in NattoPharma ASA. On the closing of the above transaction, TG Montgomery AS has entered into binding agreements to sell 571 429 shares to Pro AS (org. nr. 941 869 424) at a price of NOK 10,50 per share.

Redeye: Orphazyme - Bringing the heat

We initiate coverage of Orphazyme, a Danish pure-play orphan drug company with a late-stage pipeline. Multiple key clinical readouts are lined up for 2018-2021 and lead project arimoclomol could reach the market by 2020. We value the company at DKK 110 in our Base Case, with Bull and Bear Case at DKK 200 and DKK 35 per share, respectively. Read more and download the initial research report: https://goo.gl/2hdxxb Start following companies at Redeye to recieve the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered

KappAhl Q3 2017/2018: Strong sales in May resulted in a good quarter

“....Sales for the quarter started cautiously but gradually increased. Attractive campaigns and an efficient supply chain have contributed to fewer clearance sales and a sound gross margin...”                        Read the full CEO statement in the report.· Sales increased by 2.1 per cent  in the quarter. During the period September-May they decreased by 4.0 per cent.  · The gross margin for the quarter was 64.5 (63.7) per cent. Accumulated for the period September-May it was 62.7 (62.7) per cent.   · The operating profit was SEK 121 (119) million for the quarter and SEK 216 (310)

SpareBank 1 SR-Bank ASA (SRBANK): Notification of positive financial one-off effect on Q2 results in 2018

In connection with the merger of Vipps AS, BankAxept AS and BankID Norge AS, a new valuation of the latter two companies has been set. As a result of the transaction, the bank will have to make a write-up of the book value.  The company resulting from the merger of Vipps AS, BankAxept AS and BankID Norge AS will have a total value of NOK 3.9 billion on the date of completion for the merger.  Following the merger, the SpareBank 1 banks will have a total stake of 22.04 %, worth approximately NOK 860 million. The stakes held by individual SpareBank 1 banks will vary.  In the case of

Asetek Announces Eleven Installations in the TOP500 Supercomputer List

Nine Systems in Top200 and Highest Performing System in JapanJune 27, 2018 – Asetek ® (ASETEK.OL) today announced that its RackCDU D2C™ (Direct-to-Chip ) liquid cooling technology is cooling eleven installations in the June 2018 edition of the TOP500 list of the fastest supercomputers in the world, including nine systems in the Top200. Ranked 5th on the Top500 list is the AI Bridging Cloud Infrastructure system (ABCI) installed at the National Institute of Advanced Industrial Science and

BioArctic announces changes in the Management Team effective September 1, 2018

Stockholm, Sweden, June 27, 2018 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that professor Lars Lannfelt resumes his employment in the company as of September 1, 2018. Professor Lannfelt is one of the two founders, member of the Board, the largest owner and has today a consultancy role in the company. In the future he will work full-time as scientific expert with new discovery opportunities and continue to be the company's contact person in the strategically important collaborations with research groups at the universities. Associate Professor Pär Gellerfors founded

Invitation to Kungsleden’s presentation of the interim period January - June 2018 on July 11 at 1:00 pm (CET)

On July 11, 2018 at 7.00 am (CET) Kungsleden AB (publ) will publish its first interim report for January - June 2018.Accordingly, Kungsleden invites investors, asset managers, financial analysts and the press to a presentation where CEO Biljana Pehrsson and Deputy CEO and CFO Anders Kvist will present and comment on the interim period. The report will be published at 7:00 am and is available to download at www.kungsleden.se/financialreports. Follow the presentation via telephone conference or audio broadcast at1:00 pm The presentation will be held in English via a telephone

Interim report for the period 1 September 2017 - 31 May 2018

Increased earnings and stronger e-commerce sales E-commerce sales continued to increase sharply, and were up by 65% in the quarter year on year. Brothers’ e-commerce sales doubled in the quarter. Polarn O. Pyret’s e-commerce sales increased by more than 40% in the quarter, with e-commerce comprising 16% of total net sales. Operating income increased to SEK 6 M (2) in the third quarter.THIRD QUARTER, MARCH 1, 2018 – MAY 31, 2018 IN SUMMARY ·  Net sales were SEK 510 M (490). ·  Sales for comparable stores in the Group increased by 2.2 percent. ·  Sales for comparable stores in

LUCARA ANNOUNCES UPDATED MINERAL RESOURCE FOR KAROWE MINE

VANCOUVER, BC, June 26, 2018 /CNW/ - (LUC – TSX, LUC – BSE, LUC – Nasdaq Stockholm) Lucara Diamond Corp. (“Lucara” or the “Company”) is pleased to announce the results of the Mineral Resource Update prepared in accordance with National Instrument 43-101 (“NI43-101”). These new results will be used for mine planning and to support the preparation of current feasibility-level studies for the potential development of an underground mine, after the completion of the current open pit mine, at its Karowe Mine (”Karowe Mine”) in Botswana. Highlights and Updated Mineral Resource Statement ·

Publication of Final Terms

Regulatory Announcement Royal Bank of CanadaJune 26, 2018 Publication of Final Terms Not for release, publication or distribution, directly or indirectly, in or into the United States. Royal Bank of Canada has agreed to issue EUR1,500,000,000 0.25 per cent.  Covered Bonds due June 28, 2023, Series CB37 (the "Covered Bonds") pursuant to the €32,000,000,000 Global Covered Bond Programme of Royal Bank of Canada, unconditionally and irrevocably guaranteed as to payments by RBC Covered Bond Guarantor Limited Partnership (the "Programme"). The following document constitutes the

There are no items matching the current filter
There are no more items matching the current filter
Back to top